# Neurostimulation for Cognitive Enhancement in Alzheimer's Disease

> **NCT04404153** · NA · COMPLETED · sponsor: **Albert Einstein College of Medicine** · enrollment: 100 (actual)

## Conditions studied

- Alzheimer Disease
- Dementia

## Interventions

- **DEVICE:** tDCS device model Soterix mini-CT (Soterix Medical Inc., New York, NY) programed to deliver active tDCS.
- **DEVICE:** tDCS device model Soterix mini-CT (Soterix Medical Inc., New York, NY) programed to deliver sham tDCS.

## Key facts

- **NCT ID:** NCT04404153
- **Lead sponsor:** Albert Einstein College of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-25
- **Primary completion:** 2025-10-28
- **Final completion:** 2026-02-19
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2026-04-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04404153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04404153, "Neurostimulation for Cognitive Enhancement in Alzheimer's Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04404153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*